Clinical Trial Update: The Role of Mineralocorticoid Receptors in Vascular Function [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update reporting results from Phase 2 and Phase 3 studies on the role of mineralocorticoid receptors in vascular function for Apparent Mineraloco…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Apparent Mineralocorticoid Excess

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Apparent Mineralocorticoid Excess (AME) | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2015-05-28